Relation of hypoxia-inducible factor-1α to vascular endothelial growth factor and vasoactive factors during healing of gastric ulcers

被引:11
|
作者
Hashimoto, H
Akimoto, M
Maeda, A
Shigemoto, M
Yamashito, K
机构
[1] JR Tokyo Gen Hosp, Dept Geriatr, Shibuya Ku, Tokyo 1518528, Japan
[2] Tokyo Womens Med Univ, Inst Geriatr, Tokyo, Japan
关键词
hypoxia-inducible factor-1 alpha; endothelin-1; inducible nitric oxide synthase; vascular endothelial growth factor; ulcer healing;
D O I
10.1097/01.fjc.0000166305.79055.ad
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the relation of hypoxia-inducible factor-1alpha (HIF-1alpha) to vascular endothelial growth factor and vasoactive factors during the healing of gastric ulcers. The gastric ulcers were divided into three stages (active stage, healing stage and scar stage). The expression of HIF-1alpha, endothelin-1, inducible nitric oxide synthase, and vascular endothelial growth factor mRNA was highest during the active stage of ulcer healing, and endothelin-1, vascular endothelial growth factor protein levels and nitric oxide were higher during the healing stage. Thus, levels of HIF-1alpha mRNA tend to increase during the active stage of gastric ulcer healing, suggesting that this factor participates in the induction of endothelin-1, inducible nitric oxide synthase, and vascular endothelial growth factor. Also, the HIF-1alpha mRNA level did not differ significantly among the various stages of ulcer healing, and detectable levels of HIF-1alpha protein were not found during any stage. This suggests that these angiogenic factors and vasoactive substances may be induced by HIF-1alpha. During the active stage on endoscopic examination, considered the initial phase of ulcer healing, the process of ulcer healing has begun, and the tissue at the ulcer margin has already been reoxygenated.
引用
收藏
页码:S407 / S409
页数:3
相关论文
共 50 条
  • [31] Overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in sacral giant cell tumors and the correlation with tumor microvessel density
    Fu, Shaofeng
    Bai, Rui
    Zhao, Zhenqun
    Zhang, Zhifeng
    Zhang, Gang
    Wang, Yuxin
    Wang, Yong
    Jiang, Dianming
    Zhu, Dezhi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (05) : 1453 - 1458
  • [32] Clinical implications of serum hypoxia inducible factor-1α and vascular endothelial growth factor in lung cancer
    Shen, Hong
    Feng, Ganzhu
    Cui, Jin
    Du, Qiang
    Qin, Yong
    Cai, Jiankang
    Shen, Li
    Zhu, Yina
    TUMORI, 2015, 101 (04) : 404 - 411
  • [33] Expression of hypoxia-inducible angiogenic proteins (hypoxia-inducible factor-1α, vascular endothelial growth factor, and E26 transformation-specific-1) and plaque hemorrhage in human carotid atherosclerosis
    Higashida, Tetsuhiro
    Kanno, Hiroshi
    Nakano, Masato
    Funakoshi, Kengo
    Yamamoto, Isao
    JOURNAL OF NEUROSURGERY, 2008, 109 (01) : 83 - 91
  • [34] Expression of hypoxia-inducible factor-1α in the brain of rats during chronic hypoxia
    Chávez, JC
    Agani, F
    Pichiule, P
    LaManna, JC
    JOURNAL OF APPLIED PHYSIOLOGY, 2000, 89 (05) : 1937 - 1942
  • [35] Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival
    Huang, Geng-Wen
    Yang, Lian-Yue
    Lu, Wei-Qun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (11) : 1705 - 1708
  • [36] Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia
    Zhang, Tao
    Mao, Changlin
    Chang, Yao
    Lyu, Jiaju
    Zhao, Delong
    Ding, Sentai
    CURRENT UROLOGY, 2024, 18 (03) : 185 - 193
  • [37] Transfection of hypoxia-inducible factor-1 decoy oligodeoxynucleotides suppresses expression of vascular endothelial growth factor in oral squamous cell carcinoma cells
    Imai, Mie
    Ishibashi, Hiroaki
    Nariai, Yoshiki
    Kanno, Takahiro
    Sekine, Joji
    Onimaru, Mitsuho
    Mori, Yoshihide
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2012, 41 (09) : 675 - 681
  • [38] Concentration of hypoxia-inducible factor-1, glucose transporter 1 and vascular endothelial growth factor in tissue samples and serum in patients with primary laryngeal carcinoma
    Bronikowska, Izabela
    Swietochowska, Elzbieta
    Morawski, Robert
    Sowa, Pawel
    Czecior, Eugeniusz
    ACTA OTO-LARYNGOLOGICA, 2022, 142 (06) : 532 - 536
  • [39] Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors
    Moschetta, Marina Gobbe
    Maschio, Larissa Bazela
    Jardim-Perassi, Bruna Victorasso
    Gelaleti, Gabriela Bottaro
    Lopes, Juliana Ramos
    Leonel, Camila
    Goncalves, Naiane Do Nascimento
    Ferreira, Livia Carvalho
    Martins, Gustavo Rodrigues
    Borin, Thaiz Perraz
    Pires De Campos Zuccari, Debora Aparecida
    ONCOLOGY REPORTS, 2015, 33 (05) : 2345 - 2353
  • [40] Effects of the hypoxia-inducible factor-1 inhibitor echinomycin on vascular endothelial growth factor production and apoptosis in human ectopic endometriotic stromal cells
    Tsuzuki, Tomoko
    Okada, Hidetaka
    Shindoh, Hisayuu
    Shimoi, Kayo
    Nishigaki, Akemi
    Kanzaki, Hideharu
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (04) : 323 - 328